Phase 2 Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Not Achieving Glycemic Targets Despite GLP-1-Based Therapy
NCT07502508 · RECRUITING · Phase 2
We track 2 ClinicalTrials.gov studies led by Biomea Fusion Inc. The portfolio skews toward Phase 2 (2 trials).
2 clinical trials sponsored by Biomea Fusion Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 2 | 100% |
Biomea Fusion Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2.
Biomea Fusion Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Biomea Fusion Inc currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.